Inactive Instrument
Epigenomics AG Stock Deutsche Boerse AG
Stocks
DE000A0BVT96
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 22/07/25 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 789K 909K 736K 676K 1.28M 86.47M 1.29M 8.68M 3.39M 43.22M 3.41M 3.34M 143M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.76M 13.54M 10.96M 10.07M 19.04M 1.29B 19.25M 129M 50.52M 644M 50.84M 49.73M 2.13B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 01/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 01/03/2023 |
Alexander Link
BRD | Director/Board Member | 55 | 01/06/2020 |
Jochen Hummel
BRD | Director/Board Member | 56 | 05/02/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.23% | +9.01% | +125.02% | +259.44% | 3.68B | |
| +3.48% | -16.60% | +90.83% | +81.64% | 3.61B | |
| -1.59% | +31.72% | +273.73% | +324.23% | 2.48B | |
| +2.61% | +5.38% | -27.47% | -35.38% | 2.16B | |
| +1.04% | -7.23% | +54.06% | -39.78% | 1.93B | |
| +0.16% | -6.27% | +183.26% | -44.09% | 947M | |
| +4.68% | +6.68% | -4.28% | +10.47% | 850M | |
| -0.46% | +3.70% | -38.25% | -11.10% | 519M | |
| +8.68% | +9.39% | +1.08% | - | 464M | |
| Average | +2.76% | +5.54% | +73.11% | +68.18% | 1.85B | |
| Weighted average by Cap. | +2.83% | +3.71% | +99.88% | +115.06% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.64K 22.38K 20.56K 38.88K 2.63M 39.3K 264K 103K 1.31M 104K 102K 4.35M |
| Net income | -3.35M -3.86M -3.13M -2.87M -5.43M -367M -5.49M -36.85M -14.4M -184M -14.5M -14.18M -608M | -314K -362K -293K -269K -509K -34.4M -514K -3.45M -1.35M -17.2M -1.36M -1.33M -56.98M |
| Net Debt | 10.46M 12.04M 9.75M 8.95M 16.94M 1.15B 17.12M 115M 44.93M 573M 45.22M 44.23M 1.9B | 10.97M 12.63M 10.23M 9.39M 17.77M 1.2B 17.96M 121M 47.13M 601M 47.43M 46.39M 1.99B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
